Dr. Emily Lauren Kellogg, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 45 Dimock St, Roxbury, MA 02119 Phone: 617-442-8800 Fax: 617-541-8334 |
Alice Han, MD MSC FRCSC Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 55 Dimock St, Roxbury, MA 02119 Phone: 617-442-9663 |
Katharyn M Atkins, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 55 Dimock St, Roxbury, MA 02119 Phone: 617-442-8800 |
Kelly Flynn, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 55 Dimock St, Roxbury, MA 02119 Phone: 617-442-8800 Fax: 617-541-8334 |
Jennifer Ann Scott, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 55 Dimock St, Dimock Community Health Center, Roxbury, MA 02119 Phone: 617-442-8800 |
News Archive
Deficiency of vitamin D is a common problem for patients with severe burn injuries and can lead to further health compromise. However, there are no evidence-based guidelines for vitamin D replenishment in such patients.
Investments in cloud-based laboratory information management systems are part of Europe's eHealth strategy.
A University of Oklahoma team of chemists has developed a new antibiotic formulation to fight the sometimes deadly staph infection caused by methicillin-resistant S. aureus or MRSA and other antibiotic-resistant infectious bacteria.
Quite an "only in Massachusetts" moment. Patriots owner Robert Kraft and leaders of Raytheon, Suffolk Construction and Putnam Investments have all filed letters in support of an anti-trust agreement that would not normally see the light of day before a judge approves the deal. The opposition includes public health professors, a group of top economists and politicians battling Attorney General Martha Coakley in the governor's race. This show of force is weighing in on a deal Coakley negotiated with Partners HealthCare. It would let the state's largest hospital network expand its market power, but with constraints, some of which would last for 10 years (Bebinger, 7/24).
The ability to reliably and safely make in the laboratory all of the different types of cells in human blood is one key step closer to reality.
› Verified 9 days ago